These findings suggest that decreased m6A methylation levels are consistently observed across different cohorts and sample types in T2DM, whereas the regulatory roles of FTO may be complex due to sample or cellular heterogeneity. The gene discussed is FTO; the disease is type 2 diabetes mellitus.